Medications

Patent granted for drug candidate intended for cancer treatment

A potential new drug candidate developed by researchers at the University of Oulu, Finland, has been granted a patent in the United States. The drug is a small molecular chemical compound that is especially suited for cancer ...

Vaccination

Why aren't COVID vaccines getting to people globally?

(HealthDay)—The highly transmissible Delta variant of COVID-19 has highlighted a fear shared by infectious disease experts worldwide: That increasingly dangerous mutations will continue to crop up until most people around ...

Vaccination

WHO boss says vaccine IP waiver not a property 'snatch'

The World Health Organization on Wednesday sought to reassure pharmaceutical companies that a proposal to suspend patent rights on COVID-19 vaccines was not a bid to "snatch" their intellecutual property rights.

Vaccination

EU lawmakers back COVID vaccines patent waiver

The European Parliament has urged the EU to back a push for a temporary waiver of coronavirus vaccine patents, in the face of scepticism from Brussels and key member states.

Cardiology

Q&A: Treatment for patent foramen ovale

DEAR MAYO CLINIC: I'm 36 and do not have any significant medical concerns, but due to a family member's heart health issues, it was recommended I have a cardiac evaluation. After undergoing an echocardiogram, I was surprised ...

Vaccination

Beyond vaccines, UNESCO seeks share more global science

While the U.S. president is calling for suspending patents on COVID-19 vaccines, experts at UNESCO are quietly working on a more ambitious plan: a new global system for sharing scientific knowledge that would outlast the ...

Vaccination

Merkel urges US to export COVID vaccines

German Chancellor Angela Merkel on Saturday urged the United States to export coronavirus vaccines made on its soil, as she rejected a patent waiver call from Washington for the jabs.

Vaccination

EU says US stand on patent virus waiver is no 'magic bullet'

European Union leaders cranked up their criticism of the U.S. call to waive COVID-19 vaccine patents Saturday, arguing the move would yield no short-term or intermediate improvement in vaccine supplies and could even have ...

page 19 from 26